Rockcliffe Labs Launches $75 Million Canadian Development Financing at $10 per Share, Reflecting $300 Million Post-Money Valuation; Executes License with a Canadian University for a Late-Stage Sepsis Biomarker–Based Program
TORONTO, Oct. 02, 2025 (GLOBE NEWSWIRE) — Rockcliffe Labs Inc. ("Rockcliffe Labs" or the "Company"), a Canadian biotechnology venture creation platform, announces the launch of a $75 million non-brokered private placement in Canada (the "Offering") at $10.00
(Financial Post, 2025-10-02T20:40:33Z)